BACKGROUND AND OBJECTIVES: Malformations of cortical development (MCD), though individually rare, constitute a significant burden of disease. The diagnostic yield of next-generation sequencing (NGS) in these patients varies across studies and methods, and novel genes and variants continue to emerge. METHODS: Patients (n = 123) with a definite radiologic or histopathologic diagnosis of MCD, with or without epilepsy were included in this study. They underwent NGS-based targeted gene panel (TGP) testing, whole-exome sequencing (WES), or WES-based virtual panel testing. Selected patients who underwent epilepsy surgery (n = 69) also had somatic gene testing of brain tissue-derived DNA. We analyzed predictors of positive germline genetic finding and diagnostic yield of respective methods. RESULTS: Pathogenic or likely pathogenic germline genetic variants were detected in 21% of patients (26/123). In the surgical subgroup (69/123), we performed somatic sequencing in 40% of cases (28/69) and detected causal variants in 18% (5/28). Diagnostic yield did not differ between TGP, WES-based virtual gene panel, and open WES (p = 0.69). Diagnosis of focal cortical dysplasia type 2A, epilepsy, and intellectual disability were associated with positive results of germline testing. We report previously unpublished variants in 16/26 patients and 4 cases of MCD with likely pathogenic variants in non-MCD genes. DISCUSSION: In this study, we are reporting genetic findings of a large cohort of MCD patients with epilepsy or potentially epileptogenic MCD. We determine predictors of successful ascertainment of a genetic diagnosis in real-life setting and report novel, likely pathogenic variants in MCD and non-MCD genes alike.

Department of Paediatric Neurology 2nd Faculty of Medicine Charles University and Motol University Hospital Czech Republic

Zobrazit více v PubMed

Harvey AS, Cross JH, Shinnar S, Mathern GW, Mathern BW, ILAE Pediatric Epilepsy Surgery Survey Taskforce. Defining the spectrum of international practice in pediatric epilepsy surgery patients. Epilepsia. 2008;49(1):146-155. PubMed

Blumcke I, Spreafico R, Haaker G, et al. , EEBB Consortium. Histopathological findings in brain tissue obtained during epilepsy surgery. N Engl J Med. 2017;377(17):1648-1656. PubMed

Lamberink HJ, Boshuisen K, van Rijen PC, Gosselaar PH, Braun KPJ, Dutch Collaborative Epilepsy Surgery Program DCESP. Changing profiles of pediatric epilepsy surgery candidates over time: a nationwide single-center experience from 1990 to 2011. Epilepsia. 2015;56(5):717-725. PubMed

Oegema R, Barakat TS, Wilke M, et al. . International consensus recommendations on the diagnostic work-up for malformations of cortical development. Nat Rev Neurol. 2020;16(11):618-635. PubMed PMC

Lee S, Kim SH, Kim B, et al. . Clinical implementation of targeted gene sequencing for malformation of cortical development. Pediatr Neurol. 2020;103:27-34. PubMed

Sim NS, Ko A, Kim WK, et al. . Precise detection of low-level somatic mutation in resected epilepsy brain tissue. Acta Neuropathol. 2019;138:901-912. PubMed

Stevelink R, Sanders MW, Tuinman MP, et al. . Epilepsy surgery for patients with genetic refractory epilepsy: a systematic review. Epileptic Disord. 2018;20(2):99-115. PubMed

Sanders MWCB, Lemmens CMC, Jansen FE, Brilstra EH, Koeleman BPC, Braun KPJ, Dutch Collaborative Epilepsy Surgery Program LWEC. Implications of genetic diagnostics in epilepsy surgery candidates: a single-center cohort study. Epilepsia Open. 2019;4(4):609-617. PubMed PMC

Fisher RS, Acevedo C, Arzimanoglou A, et al. . ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482. PubMed

Severino M, Geraldo AF, Utz N, et al. . Definitions and classification of malformations of cortical development: practical guidelines. Brain. 2020;143:2874-2894. PubMed PMC

Guerrini R, Duchowny M, Jayakar P, et al. . Diagnostic methods and treatment options for focal cortical dysplasia. Epilepsia. 2015;56(11):1669-1686. PubMed

Kwan P, Arzimanoglou A, Berg AT, et al. . Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-1077. PubMed

Blumcke I, Thom M, Aronica E, et al. . The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia. 2011;52(1):158-174. PubMed PMC

Benova B, Sanders MWCB, Uhrova-Meszarosova A, et al. . GATOR1-related focal cortical dysplasia in epilepsy surgery patients and their families: a possible gradient in severity? Eur J Paediatr Neurol. 2021;30:88-96. PubMed

Galer PD, Ganesan S, Lewis-Smith D, et al. . Semantic similarity analysis reveals robust gene-disease relationships in developmental and epileptic encephalopathies. Am J Hum Genet. 2020;107(4):683-697. PubMed PMC

Richards S, Aziz N, Bale S, et al. , ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424. PubMed PMC

Blumcke I, Aronica E, Miyata H, et al. . International recommendation for a comprehensive neuropathologic workup of epilepsy surgery brain tissue: a consensus Task Force report from the ILAE Commission on Diagnostic Methods. Epilepsia. 2016;57(3):348-358. PubMed

Najm I, Lal D, Alonso Vanegas M, et al. . The ILAE consensus classification of focal cortical dysplasia: an update proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia. 2022;63:1899-1919. PubMed PMC

Bienvenu T, des Portes V, Saint Martin A, et al. . Non-specific X-linked semidominant mental retardation by mutations in a Rab GDP-dissociation inhibitor. Hum Mol Genet. 1998;7(8):1311-1315. PubMed

Strobl-Wildemann G, Kalscheuer VM, Hu H, Wrogemann K, Ropers HH, Tzschach A. Novel GDI1 mutation in a large family with nonsyndromic X-linked intellectual disability. Am J Med Genet A. 2011;155a(12):3067-3070. PubMed

des Portes V, Billuart P, Carrié A, et al. . A gene for dominant nonspecific X-linked mental retardation is located in Xq28. Am J Hum Genet. 1997;60(4):903-909. PubMed PMC

D'Adamo P, Menegon A, Lo Nigro C, et al. . Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat Genet. 1998;19(2):134-139. PubMed

Tran Mau-Them F, Guibaud L, Duplomb L, et al. . De novo truncating variants in the intronless IRF2BPL are responsible for developmental epileptic encephalopathy. Genet Med. 2019;21(4):1008-1014. PubMed

Marcogliese PC, Shashi V, Spillmann RC, et al. . IRF2BPL is associated with neurological phenotypes. Am J Hum Genet. 2018;103(2):456-460. PubMed PMC

Beck DB, Petracovici A, He C, et al. . Delineation of a human mendelian disorder of the DNA demethylation machinery: TET3 deficiency. Am J Hum Genet. 2020;106(2):234-245. PubMed PMC

Hiraide T, Hattori A, Ieda D, et al. . De novo variants in SETD1B cause intellectual disability, autism spectrum disorder, and epilepsy with myoclonic absences. Epilepsia Open. 2019;4(3):476-481. PubMed PMC

Roston A, Evans D, Gill H, et al. . SETD1B-associated neurodevelopmental disorder. J Med Genet. 2021;58(3):196-204. PubMed

Helbig I, Lopez-Hernandez T, Shor O, et al. . A recurrent missense variant in AP2M1 impairs clathrin-mediated endocytosis and causes developmental and epileptic encephalopathy. Am J Hum Genet. 2019;104(6):1060-1072. PubMed PMC

Vetro A, Nielsen HN, Holm R, et al. . ATP1A2- and ATP1A3-associated early profound epileptic encephalopathy and polymicrogyria. Brain. 2021;144:1435-1450. PubMed

Monteiro FP, Curry CJ, Hevner R, et al. . Biallelic loss of function variants in ATP1A2 cause hydrops fetalis, microcephaly, arthrogryposis and extensive cortical malformations. Eur J Med Genet. 2020;63(1):103624. PubMed

Chatron N, Cabet S, Alix E, et al. . A novel lethal recognizable polymicrogyric syndrome caused by ATP1A2 homozygous truncating variants. Brain. 2019;142(11):3367-3374. PubMed

Bianchi V, Farisello P, Baldelli P, et al. . Cognitive impairment in Gdi1-deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training. Hum Mol Genet. 2009;18(1):105-117. PubMed PMC

French JA, Lawson JA, Yapici Z, et al. . Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016;388(10056):2153-2163. PubMed

Vawter-Lee M, Franz DN, Fuller CE, Greiner HM. Clinical Letter: a case report of targeted therapy with sirolimus for NPRL3 epilepsy. Seizure. 2019;73:43-45. PubMed

Lai D, Gade M, Yang E, et al. . Somatic variants in diverse genes leads to a spectrum of focal cortical malformations. Brain. 2022;145:2704-2720. PubMed PMC

Baldassari S, Ribierre T, Marsan E, et al. . Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Acta Neuropathologica. 2019;138(6):885-900. PubMed PMC

Cellini E, Vetro A, Conti V, et al. . Multiple genomic copy number variants associated with periventricular nodular heterotopia indicate extreme genetic heterogeneity. Eur J Hum Genet EJHG. 2019;27(6):909-918. PubMed PMC

Guerrini R, Dobyns WB. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol. 2014;13(7):710-726. PubMed PMC

Kim S, Baldassari S, Sim NS, et al. . Detection of brain somatic mutations in CSF from refractory epilepsy patients. Ann Neurol. 2021;89(6):1248-1252. PubMed

A new perspective on drug-resistant epilepsy in children with focal cortical dysplasia type 1: From challenge to favorable outcome

COL4A1 mutation-related disorder presenting as fetal intracranial bleeding, hydrocephalus, and polymicrogyria